Transmission Dynamics of MDR-TB and XDR-TB in Areas of Varying HIV Prevalence  by Victor, T.C. et al.
(Ora
1
i
a
d
t
c
b
t
i
m
d
(
o
t
s
w
o
s
a
o
4
s
a
p
c
d
7
T
V
T
E
J
1
2
o
d
l
u
s
p
R
i
d
H
i
d
s
r
f
c13th International Congress on Infectious Diseases Abstracts
ues for 7vCRM1, country-speciﬁc IPD serotype distribution
and serotype-speciﬁc immunological differences between
PHiD-CV and 7vCRM when co-administered at 6-10-14 weeks
of age with DTPw-HBV/Hib and OPV vaccines in the Philip-
pines (abstract# 3.002). SSVE’s for PHiD-CV (each serotype in
common with 7vCRM and 6A) were obtained by multiplying
7vCRM SSVE’s by the ratio of the percentages of PHiD-
CV- versus 7vCRM-vaccinated children reaching a predeﬁned
immunogenicity threshold one month after 3 primary doses.
SSVE’s for 19A (both vaccines) and for 1, 5, 7F (PHiD-CV)
were set essentially equivalent to the % children achiev-
ing the threshold for each seratype. The overall impact of
each vaccine in country-j (IPD-IEoverallj) is shown in equation
1 below.
Results: Using the 0.2g/mL threshold (22F-ELISA) as
basis of comparison and applying the IPD-IE to IPD serotype
data from several countries, PHiD-CV is estimated to pre-
vent approximately 59—85% of IPD while 7vCRM would
prevent 36—75% as shown in table below. Similar results
were obtained using ELISA 0.35g/mL or OPA 1:8 as immuno-
logical thresholds for comparison. Since countries might be
using different immunization schedules or DTPa-based co-
administered vaccines; IPD-IEs were also computed using
immunogenicity data from a European study in which
PHiD-CV or 7vCRM were co-administered with DTPa-HBV-
IPV +Hib-MenC at 2-4-6 months of age. Calculated IPD-IEs
(PHiD-CV: 57—80%; 7vCRM: 36—74%) were within the same
range as those mentioned above.
Conclusions: PHiD-CV would be predicted to prevent
59—85% of IPD in children depending on the relative impor-
tance of serotypes 1, 5, 7F in the above noted Middle East
and Asian countries.
Reference
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The activities of the antimalarial drugs- artesunate and
amodiaquine against intestinal helminth were evaluated in
l
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09 of 242 Nigerian children with uncomplicated Plasmod-
um falciparum malaria who had helminth before, during
nd after treatment with the two therapies. The chil-
ren were randomized to the standard dose regimens of
he drugs. Clinical recovery from malaria occurred in all
hildren. Helminth was detected in 102 patients (93.6%)
efore treatment and in another 7 patients (6.4%) after
reatment. The children treated with artesunate had sim-
lar pretreatment helminth ova load, signiﬁcantly shorter
alaria parasite clearance times (1.3 + 0.5 versus 2.8 + 1.8
, P = 0.0001), high total parasite reduction potential in 24 h
TPRP24h) (P = 0.0001) and lower geometric mean helminth
va load by day 14 (P = 0.012) following treatment than
hose treated with amodiaquine. However, helminth para-
ite excretion time was signiﬁcantly shorter in those treated
ith amodiaquine (P = 0.003). Kaplan-Meier survival curve
f cumulative probability of remaining helminth ova career
howed that by day 14 of follow-up, children treated with
rtesunate had signiﬁcant propensity to still carry helminth
va than in amodiaquine treated children (Log rank statistics
.67, df = 1, P = 0.03). These results suggest that both arte-
unate and amodiaquine not only clear malaria parasite, but
lso offer considerable anti-helminth activity that is more
ronounced with amodiaquine-an additional advantage for
ombination therapy.
oi:10.1016/j.ijid.2008.05.005
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ransmission Dynamics of MDR-TB and XDR-TB in Areas of
arying HIV Prevalence
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Background and aim: There have been many reports
n co-infection with HIV and Tuberculosis, however, the
isease dynamics of drug-resistant Mycobacterium tubercu-
osis strains in areas of high HIV prevalence remains largely
nknown. This study aimed to investigate the population
tructure of drug-resistant strains in settings of high HIV
revalence in South Africa.
Methods: A molecular epidemiological approach (IS6110-
FLP, spoligotyping, MIRU-typing, drug-resistance genotyp-
ng, phylogenetic tree analysis) was used to study the
ynamics of drug-resistant strains in 3 settings with different
IV prevalence’s (Western Cape, Eastern Cape and a mine
n the Northern Province).
Results: Cluster analysis showed that more than 60% of
rug-resistant TB was due to the transmission of resistant
trains in the 3 study settings. A hyper transmissible drug-
esistant clone with the Beijing genotype was responsible
or the signiﬁcant increase in the number of drug-resistant
ases in the Western Cape setting over a 5 year period. Phy-
ogenetic analysis, of isolates collected in the mine setting,
oupled with contact tracing, demonstrated how MDR-
B acquired additional resistance markers (pyrazinamide,
thambutol and oﬂoxacin) in a stepwise manner despite
n excellent TB control program. This stepwise evolution
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ulminated in the emergence of XDR-TB. In the Eastern
ape setting the molecular epidemiological data showed
hat the atypical Beijing genotype (attenuated phenotype)
an become virulent and spread in patients infected with HIV
espite the acquisition of resistance markers which have a
tness cost.
Conclusion: Our results raise concern for the spread of all
rug-resistant strains in vulnerable populations. Greater vig-
lance is required to contain the drug-resistant TB epidemic
n high HIV prevalence settings. This can be achieved by
he development and implementation of rapid diagnostics,
nsuring treatment adherence and intensiﬁed screening of
ontacts. However, in order for diagnosis and treatment to
e effective it is essential that communities are educated
o improve health seeking behavior.
oi:10.1016/j.ijid.2008.05.006
.003
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Nipah virus (NiV) emerged in Malaysia in 1998 as a res-
iratory and neurologic disease in pigs and caused a severe
ebrile encephalitis in humans, carrying a 40% mortality rate
n = 265). Bats of the genus Pteropus are considered a natu-
al reservoir for Nipah virus and other related henipaviruses.
e proposed two hypotheses for NiV emergence: 1) Nipah
irus is endemic and circulating in pteropid bats through-
ut Malaysia and these bats normally occurred in the area
f the index farm where Nipah virus emerged; and 2) the
ntensiﬁcation of pig farms in Malaysia enabled sustained
iV epidemics to occur in pigs, facilitating NiV emergence
n humans. We performed cross-sectional serological surveys
f Pteropus vampyrus and P. hypomelanus from spatially
isparate colonies across Peninsular Malaysia. A longitudi-
al sero-survey of P. hypomelanus from a single population
n Tioman Island was conducted between October 2003
nd November 2006. Bat population counts and satellite
elemetry were used to assess abundance and long-range
ovements of P. vampyrus. We also analyzed livestock pro-
uction data from the index farm and modeled within-farm
nfection dynamics.
o
(
t
y
≥ngress on Infectious Diseases Abstracts (Oral Presentations)
Serological studies showed a widespread distribution of
ipah virus antibodies in both species of Pteropus bats in
eninsular Malaysia and provided evidence for continued
iral circulation in bats. Results from the pig farm analyses
uggest that repeated introduction of NiV from the wildlife
eservoir into this intensively managed pig population led
o changes in infection dynamics in the pigs. Long-term
ithin-farm persistence permitted regional spread of the
irus, ultimately producing widespread human infection.
hus, while pteropid bats have likely been the reservoir
or Nipah virus for a long time, the cause of emergence of
iV can be essentially characterized as due to agricultural
ntensiﬁcation. Targeted surveillance of these farms in areas
here ﬂying fox distributions overlap commercial pig farms
s therefore important to detect spillover events early-on
nd prevent widespread infection.
oi:10.1016/j.ijid.2008.05.007
.004
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Background: Pneumococcal disease is an important cause
f mortality in developing countries. We aimed to determine
hether HIV-infection was associated with increased risk of
eath amongst invasive pneumococcal disease (IPD) cases.
Methods: Cases with IPD presenting to enhanced surveil-
ance sites as part of national laboratory-based surveillance
etween January 2003 and December 2005 were reviewed.
urveillance ofﬁcers collected epidemiologic data on cases
nd offered all cases HIV ELISA testing. Meningitis was
eﬁned as pneumococcal growth on cerebrospinal ﬂuid spec-
men culture (with or without growth from another site) and
ther IPD as pneumococcal growth from other normally ster-
le site specimens. Risk factors for death in patients with
eningitis and other IPD were evaluated using multivariable
ogistic regression.
Results: Of 11,116 reported IPD cases, 4890 (44%) pre-
ented to enhanced surveillance sites and had available
utcome data; 1154 (24%) cases of meningitis and 3736
76%) cases of other IPD. Of cases with available age,
he age distribution was: <5 years, 1770/4882 (36%); 5—24
ears, 774/4882 (16%); 25—44 years, 1693/4882 (35%);
45, 645/4882 (13%). The overall case fatality rate was
